Liver Biopsy Market Research Report Information By Type (Percutaneous, Transjugular, Laparoscopic), Indication (Nonalcoholic Fatty Liver Disease, Chronic Hepatitis B Or C), End User (Hospitals & Clinics, Diagnostic Centers)-Forecast Till 2032

Table Of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Liver Biopsy Market, By Type

6.1 Introduction

6.2 Percutaneous

6.2.1 Market Estimates & Forecast, 2017-2023

6.3 Transjugular

6.3.1 Market Estimates & Forecast, 2017-2023

6.4 Laparoscopic

6.4.1 Market Estimates & Forecast, 2017-2023

7. Global Liver Biopsy Market, By Indication

7.1 Introduction

7.2 Nonalcoholic Fatty Liver Disease

7.2.1 Market Estimates & Forecast, 2017-2023

7.3 Chronic Hepatitis B Or C

7.3.1 Market Estimates & Forecast, 2017-2023

7.4 Autoimmune Hepatitis

7.4.1 Market Estimates & Forecast, 2017-2023

7.5 Alcoholic Liver Disease

7.5.1 Market Estimates & Forecast, 2017-2023

7.6 Others

7.6.1 Market Estimates & Forecast, 2017-2023

8. Global Liver Biopsy Market, By End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2017-2023

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2017-2023

8.4 Others

8.4.1 Market Estimates & Forecast, 2017-2023

9. Global Liver Biopsy Market, By Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 U.K

9.3.1.4 Italy

9.3.1.5 Spain

9.3.1.6 Rest Of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic Of Korea

9.4.6 Rest Of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest Of The Middle East & Africa

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Cook Medical

11.1.1 Company Overview

11.1.2 Indication Overview

11.1.3 Financials

11.2 Boston Scientific Corporation

11.2.1 Company Overview

11.2.2 Indication Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.3 Hologic Inc.

11.3.1 Company Overview

11.3.2 Indication Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.4 MDxHealth

11.4.1 Company Overview

11.4.2 Indication/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.5 C. R. Bard, Inc.

11.5.1 Company Overview

11.5.2 Indication Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 Intact Medical Corporation

11.6.1 Overview

11.6.2 Indication Overview

11.6.3 Financials

11.6.4 Key Developments

11.7 Veran Medical

11.7.1 Overview

11.7.2 Indication Overview

11.7.3 Financials

11.7.4 Key Developments

11.8 Leica Biosystems

11.8.1 Overview

11.8.2 Indication Overview

11.8.3 Financials

11.8.4 Key Developments

11.9 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Medical Device Industry

13 Appendix

LIST OF TABLES

Table 1 Liver Biopsy Industry Synopsis, 2017-2023

Table 2 Global Liver Biopsy Market Estimates And Forecast, 2017-2023, (USD Million)

Table 3 Global Liver Biopsy Market By Region, 2017-2023, (USD Million)

Table 4 Global Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 5 Global Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 7 Global Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 8 North America Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 9 North America Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 11 North America Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 12 U.S. Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 13 U.S. Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 15 U.S. Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 16 Canada Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 17 Canada Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 19 Canada Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 20 South America Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 21 South America Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 23 South America Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 24 Europe Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 25 Europe Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 27 Europe Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 28 Western Europe Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 29 Western Europe Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 31 Western Europe Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 32 Eastern Europe Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 33 Eastern Europe Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 35 Eastern Europe Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 36 Asia Pacific Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 37 Asia Pacific Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 39 Asia Pacific Liver Biopsy Market By End Users, 2017-2023, (USD Million)

Table 40 Middle East & Africa Liver Biopsy Market By Types, 2017-2023, (USD Million)

Table 41 Middle East & Africa Liver Biopsy Market By Indication, 2017-2023, (USD Million)

Table 43 Middle East & Africa Liver Biopsy Market By End Users, 2017-2023, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Liver Biopsy Market

Figure 3 Segmentation Market Dynamics For Liver Biopsy Market

Figure 4 Global Liver Biopsy Market Share, By Type, 2020

Figure 5 Global Liver Biopsy Market Share, By Indication, 2020

Figure 6 Global Liver Biopsy Market Share, By End Users, 2020

Figure 7 Global Liver Biopsy Market Share, By Region, 2020

Figure 8 North America Liver Biopsy Market Share, By Country, 2020

Figure 9 Europe Liver Biopsy Market Share, By Country, 2020

Figure 10 Asia Pacific Liver Biopsy Market Share, By Country, 2020

Figure 11 Middle East & Africa Liver Biopsy Market Share, By Country, 2020

Figure 12 Global Liver Biopsy Market: Company Share Analysis, 2020 (%)

Figure 13 Cook Medical: Key Financials

Figure 14 Cook Medical: Segmental Revenue

Figure 16 Cook Medical: Geographical Revenue

Figure 17 Boston Scientific Corporation: Key Financials

Figure 18 Boston Scientific Corporation: Segmental Revenue

Figure 19 Boston Scientific Corporation: Geographical Revenue

Figure 20 Hologic Inc.: Key Financials

Figure 21 Hologic Inc.: Segmental Revenue

Figure 22 Hologic Inc.: Geographical Revenue

Figure 23 MDxHealth: Key Financials

Figure 24 MDxHealth: Segmental Revenue

Figure 25 MDxHealth: Geographical Revenue

Figure 26 Scion Medical Technologies LLC: Key Financials

Figure 27 Scion Medical Technologies LLC: Segmental Revenue

Figure 28 Scion Medical Technologies LLC: Geographical Revenue

Figure 29 C. R. Bard, Inc.: Key Financials

Figure 30 C. R. Bard, Inc.: Segmental Revenue

Figure 31 C. R. Bard, Inc.: Geographical Revenue

Figure 32 Intact Medical Corporation: Key Financials

Figure 33 Intact Medical Corporation: Segmental Revenue

Figure 34 Intact Medical Corporation: Geographical Revenue